An adverse event is any unwanted medical occurrence that happens while a person is taking a medication, using a medical device, or participating in a clinical trial. The critical detail: it does not have to be caused by the treatment. A person in a drug trial who breaks their ankle tripping on a curb has experienced an adverse event, even though the drug had nothing to do with it. This broad definition exists by design, because casting a wide net is the only way to catch safety problems that nobody anticipated.
Why Causation Doesn’t Matter at First
The formal definition, used across regulatory agencies worldwide, is deliberately open-ended: any untoward medical occurrence in a patient who has been given a medical product, regardless of whether it has a causal relationship with the treatment. This surprises most people. If you develop a headache during a clinical trial for a cholesterol drug, that headache gets recorded as an adverse event whether the drug caused it, your stress caused it, or you simply didn’t drink enough water that day.
The reason is practical. At the moment something goes wrong, nobody knows for sure what caused it. Recording everything creates a data trail that researchers and regulators can analyze later to spot patterns. If 2% of people taking a placebo get headaches but 15% of people taking the actual drug get headaches, that pattern only becomes visible because every headache was logged.
Adverse Event vs. Adverse Reaction
These two terms get used interchangeably in casual conversation, but they mean different things. An adverse event is any bad health occurrence during treatment, with no assumption about the cause. An adverse reaction (also called an adverse drug reaction) is an event where there’s at least a reasonable possibility that the treatment caused it. The distinction comes down to one word: suspicion. Once a doctor or researcher believes a causal link is plausible, the event graduates from “adverse event” to “adverse reaction.”
This also explains why the term “side effect” isn’t quite the same thing. Side effects are known, expected responses to a drug, listed on the label. Adverse events include the unknown and unexpected, which is what makes tracking them so important.
What Makes an Adverse Event “Serious”
Not all adverse events carry the same weight. Regulatory agencies like the FDA use a specific legal definition to classify certain events as serious adverse events. An event qualifies as serious if it results in any of the following:
- Death
- A life-threatening experience
- Hospitalization, including same-day admission or extension of an existing hospital stay
- A persistent or significant disability
- A congenital anomaly or birth defect
- A medical or surgical intervention needed to prevent any of the above
That last category is important. If a doctor has to intervene specifically to stop a situation from becoming life-threatening or disabling, that counts as serious even if the worst outcome was ultimately prevented.
How Doctors Determine if the Drug Caused It
Once an adverse event is recorded, clinicians use structured tools to figure out whether the treatment was actually responsible. One widely used method is the Naranjo scale, a 10-question scoring system that produces a probability rating. The questions are intuitive: Did the event appear after the drug was given? Did it improve when the drug was stopped? Did it come back when the drug was restarted? Are there other explanations?
Each answer adds or subtracts points, and the total score places the event into one of four categories. A score of 9 or higher means the drug almost certainly caused the reaction. Scores of 5 to 8 indicate a probable link. Scores of 1 to 4 suggest a possible connection, and a score of zero or below means the event was likely unrelated to the drug. This structured approach keeps causality assessments consistent rather than leaving them entirely to individual judgment.
Monitoring During Clinical Trials
Clinical trials have built-in safety checkpoints. An independent group called a Data Safety Monitoring Board periodically reviews all accumulated data from the trial, including every adverse event reported so far. These board members look for warning signals: are adverse events piling up in the treatment group compared to the placebo group? Are certain events more severe than expected?
The board has real power. It can recommend modifying the study, suspending enrollment, or shutting down the entire trial if participant safety is at risk. Before the trial even begins, the board defines specific triggers that would prompt an emergency review outside the regular schedule. This system exists because the researchers running the trial are often “blinded,” meaning they don’t know which participants received the real treatment, so they need an independent group with access to the full picture.
Tracking Problems After Approval
Safety surveillance doesn’t end when a drug or device reaches the market. Clinical trials typically involve thousands of people over a few years. Once millions of people start using a product in the real world, rarer adverse events that were statistically invisible during trials can start to surface.
The FDA manages several systems to capture these reports. The FDA Adverse Event Reporting System (FAERS) collects individual case safety reports for drugs and has stored data going back to 1968. For medical devices, a separate reporting system tracks problems. These databases are fed through MedWatch, the FDA’s central reporting program, which accepts reports from healthcare professionals, patients, and caregivers alike. International organizations maintain their own parallel databases as well.
FAERS data became significantly more accessible in 2017 when the FDA launched a public dashboard, allowing anyone to search adverse event reports. Before that, the data was only available as raw quarterly data files that required technical expertise to interpret.
How to Report an Adverse Event Yourself
You don’t need to be a healthcare professional to file a report. The FDA encourages patients, caregivers, and consumers to report serious problems with drugs, supplements, and medical devices through the MedWatch program. You can complete the MedWatch Online Reporting Form (FDA Form 3500) directly on the FDA’s website, download a printable version, or request one by calling 1-800-332-1088.
These voluntary reports are a vital part of the safety system. Many drug safety signals, the early hints that a product might be causing harm, have been detected because enough individual reports accumulated to form a recognizable pattern. A single report rarely triggers action on its own, but collectively, patient reports have led to label changes, safety warnings, and product withdrawals.